TERC and neoplasm: In order to demonstrate the role of RPL22, Kheimar and Kaufer [157] deleted TERC from MDV, thus abolishing tumorigenesis, and showed that its substitution with EBER-2 (Epstein-Barr virus-encoded RNA 2) restored tumour formation in MDV that lacked TERC.